Evidence to Date: Clinical Utility of Tremelimumab in the Treatment of Unresectable Hepatocellular Carcinoma

Zunirah Ahmed,1 Sunyoung S Lee,2 David W Victor 3rd,1,3 Sudha Kodali1,3 1Department of Medicine, Division of Gastroenterology and Hepatology, Houston Methodist Hospital, Houston, TX, USA; 2Department of Gastrointestinal (GI) Medical Oncology, the University of Texas MD Anderson Cancer Center, Housto...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Ahmed Z, Lee SS, Victor DW 3rd, Kodali S
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Dove Medical Press 2023-10-01
Serie:	Journal of Hepatocellular Carcinoma
Soggetti:	unresectable hepatocellular carcinoma immunotherapy ctla4 antibody targeted therapy
Accesso online:	https://www.dovepress.com/evidence-to-date-clinical-utility-of-tremelimumab-in-the-treatment-of--peer-reviewed-fulltext-article-JHC
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!